Liquid biopsy breakthrough tech prompts £1m seed investment for Scottish life sciences spin-out

Mark McIntyre Archangels

Funding enables new development phase supported by two high profile board appointments Scottish bio-tech company, BioCaptiva, has developed a novel next generation “liquid biopsy” technology device that could revolutionise the early diagnosis and monitoring of difficult to detect cancers. The University of Edinburgh spin-out has raised over £1m in seed funding from Edinburgh-based business angel investment syndicate, Archangels, and Scottish …

Archangels increases support for Scottish tech and life sciences companies in 2020

Graeme Thomson Archangels

Business angel syndicate ends year with appointment of IP expert to board Despite the challenges of the COVID-19 pandemic, Edinburgh-based business angel investment syndicate, Archangels, led investments of £16.3m in promising Scottish start-up and early stage companies in 2020, topping its 2019 total of £13.4m by 22%. Across 2020, the syndicate directly invested £8.1m (2019: £7.4m) in companies in the …

Investment to respond to growth in demand for integrated services at UK drug delivery company BDD

Mark McIntyre Archangels

Backing to fund the further expansion of formulation and manufacturing capabilities underpinned by strategic senior appointments Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of investment in its GMP* manufacturing capabilities alongside strategic recruitment to the senior leadership team and the Board of Directors. The £1.2m investment, has …